Learn what inventory accounting is, how it works, and key methods like FIFO, LIFO, and WAC. Includes real-world examples, ...

In the latest iteration of an ongoing partnership between the United States Military Academy West Point and Tobyhanna Army ...

Anthropic's groundbreaking study analyzes 700,000 conversations to reveal how AI assistant Claude expresses 3,307 unique values in real-world interactions, providing new insights into AI alignment and ...

Sequential choices are ubiquitous in daily life, yet making optimal decisions in such settings—where properly accounting for option value is crucial—can be challenging. This paper provides field ...

Macquarie cites valuation and its positive take on Atlassian’s potential near-term revenue outperformance for the upgrade. The company’s data center price increases of 15%-25% on contracts ...

With its $3 billion valuation and backing from the biggest names in tech and finance, the company is poised to shape the future of the creative industries. The focus remains on advancing AI ...

InvestingPro's Fair Value methodology combines multiple valuation approaches, including discounted cash flow analysis, peer comparisons, and historical trading ranges. This comprehensive approach ...

The electric two-wheeler manufacturer is now aiming for a post-money valuation of approximately ₹12,800 crore, which is lower than the previous target of ₹14,000 crore. This reduction in the ...

Ather Energy is revising its IPO expectations once again, with sources telling CNBC-TV18 that the electric two-wheeler maker is now targeting a post-money valuation of around ₹12,800 crore. This is ...

According to InvestingPro’s Fair Value tool, Senco Gold is valued at INR 354.7 per share, reflecting an 11.5% upside potential from the current market price of INR 318.2. Investors looking to assess ...

This deep value methodology screens for stocks that have low P/B and P/E ratios, along with low debt and solid long-term earnings growth. VIKING THERAPEUTICS INC (VKTX) is a mid-cap value stock in ...

When Colossal Biosciences announced its latest fundraise at a $10.2 billion valuation earlier this year, the company’s co-founder and CEO Ben Lamm told TechCrunch he believed the startup was ...